Express News | CareDx's AlloSure Heart Is Now Validated And Commercially Available For Pediatric Heart Transplant Patients Under 15

Benzinga07:09 ET

CareDx Launches Two Expanded Indications for AlloSure Testing Services

Businesswire07:05 ET

Shareholders Shouldn't Be Too Comfortable With CareDx's (NASDAQ:CDNA) Strong Earnings

Simply Wall StMar 7 05:44 ET

Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position

Yahoo FinanceMar 7 05:31 ET

CareDx Is Maintained at Neutral by HC Wainwright & Co.

Dow JonesMar 3 07:30 ET · Ratings

H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating, Cuts Target Price to $25

Moomoo NewsMar 3 06:31 ET · Ratings